Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction

被引：0
|
作者：
Maarten J. Deenen
Didier Meulendijks
Henk Boot
Marie-Cecile J. C. Legdeur
Jos H. Beijnen
Jan H. M. Schellens
Annemieke Cats
机构：
[1] The Netherlands Cancer Institute,Division of Medical Oncology, Department of Clinical Pharmacology
[2] The Netherlands Cancer Institute,Department of Molecular Pathology
[3] The Netherlands Cancer Institute,Division of Medical Oncology, Department of Gastroenterology and Hepatology
[4] Medisch Spectrum Twente,Department of Medical Oncology
[5] The Netherlands Cancer Institute,Department of Pharmacy and Pharmacology
[6] Utrecht University,Division of Clinical Pharmacology and Pharmaco
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Docetaxel; Oxaliplatin; Capecitabine; Gastric cancer; Pharmacogenetics; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1285 / 1295
页数：10
相关论文
共 50 条
  • [1] Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction
    Deenen, Maarten J.
    Meulendijks, Didier
    Boot, Henk
    Legdeur, Marie-Cecile J. C.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Cats, Annemieke
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1285 - 1295
  • [2] A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer
    Evans, Devon
    Miner, Tom
    Akerman, Paul
    Millis, Robin
    Jean, Maureen
    Kennedy, Teresa
    Safran, Howard
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04): : 346 - 349
  • [3] Phase I study of docetaxel, oxaliplatin, and capecitabine as first-line therapy to patients with advanced gastroesophageal cancer
    Schonnemann, K. R.
    Andersen, M.
    Yilmaz, M.
    Jensen, H. A.
    Vestermark, L. W.
    Pfeiffer, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] A phase II study of oxaliplatin, docetaxel, and capecitabine in advanced carcinoma of the esophagus and stomach
    Anderson, E. J.
    Safran, H.
    Miner, T.
    Shipley, J.
    Mcnulty, B.
    Akerman, P.
    Saba, N.
    Jean, M.
    Millis, R.
    Sio, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
  • [6] Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group
    Giordano, KF
    Jatoi, A
    Stella, PJ
    Foster, N
    Tschetter, LK
    Alberts, SR
    Dakhil, SR
    Mailliard, JA
    Flynn, PJ
    Nikcevich, DA
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (04) : 652 - 656
  • [7] A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction
    Malik, Imtiaz
    Bernal, Pedro
    Byrd, Janet
    [J]. CANCER INVESTIGATION, 2010, 28 (08) : 833 - 838
  • [8] A phase II study of bevacizumab, docetaxel and oxaliplatin in gastric and gastroesophageal junction (GEJ) cancer
    El-Rayes, B. F.
    Hammad, N.
    Philip, P. A.
    Shields, A. F.
    Heilbrun, L. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] A Phase 1b Trial of the Combination of Capecitabine and Erlotinib in Advanced Lung Cancer
    Kumar, Rajiv
    Lo, Karl
    Minchom, Anna R.
    Sharp, Adam
    Davidson, Michael
    Gunapala, Ranga
    Yap, Timothy
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary E. R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S547 - S548
  • [10] A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer
    Balazs Halmos
    Yuxia Jia
    Joseph A. Bokar
    Pingfu Fu
    David J. Adelstein
    Rosalyn Juergens
    Mary Beth Rodal
    Afshin Dowlati
    [J]. Investigational New Drugs, 2013, 31 : 1244 - 1250
12345